Advances in Runx2 regulation and its isoforms
1University of Kansas Med Center, The Kidney Institute/6108 WHE, 3901 Rainbow Blvd, Kansas City, KS 66160, United states.
Abstract:
During the last 10 years, we have witnessed major progress in skeleton biology. Runx2 is an accepted transcription factor essential for osteoblast development from mesenchymal stem cells and maturation into osteocytes and organize crucial events during bone formation. Alternations in Runx2 expression levels are associated with skeletal diseases. In vitro and in vivo studies have reported that multiple integrated complex path ways (such as Wnt/LRP5/beta-catenin, BMP/Smads, 1, 25-(OH)2-vitaminD3/VDR/VDRE pathway, etc.) and several regulatory proteins (such as Msx2, Dlx5, Twists, etc.) play critical roles in modulating Runx2 gene expression, activity, and the subsequent bone formation. These findings provide novel insights through controlling osteoblast differentiation to treat osteoporosis or other bone diseases with altered bone mass by stimulating Runx2 expression. Further studies have shown that expression of RUNX2 is initiated from two promoters, the distal P1 promoter and the proximal P2 promoter. The alternative use of promoters gives rise to the genesis of two major protein isoforms with distinct amino termini, named as Runx2-TypeI and Runx2-TypeII. Here, we also review a complex spatio-temporal pattern of two major isoforms expressions and their possible function differences in skeleton development.
Insights
Runx2 is crucial for bone formation and osteoblast development. Understanding its regulation and isoforms offers new therapeutic targets for skeletal diseases like osteoporosis.
Area of Science:
- Skeletal Biology
- Molecular Biology
- Developmental Biology
Background:
- Runx2 is a key transcription factor regulating osteoblast differentiation and bone formation.
- Altered Runx2 expression is linked to various skeletal diseases.
- Multiple signaling pathways and regulatory proteins modulate Runx2 activity.
Purpose of the Study:
- To review the regulatory mechanisms of Runx2 in bone development.
- To explore the role of Runx2 isoforms in skeletal biology.
- To highlight therapeutic potential for bone diseases by modulating Runx2.
Main Methods:
- Literature review of in vitro and in vivo studies on Runx2.
- Analysis of signaling pathways (Wnt, BMP, Vitamin D) affecting Runx2.
- Examination of regulatory proteins influencing Runx2 expression and activity.
Main Results:
- Runx2 expression is controlled by complex integrated pathways and regulatory proteins.
- Two major Runx2 isoforms (Type I and Type II) arise from alternative promoter usage.
- These isoforms exhibit distinct amino termini and spatio-temporal expression patterns.
Conclusions:
- Modulating osteoblast differentiation via Runx2 offers therapeutic strategies for bone diseases.
- Understanding Runx2 isoform-specific functions is critical for skeletal development.
- Further research into Runx2 regulation and isoforms can advance treatments for osteoporosis and other bone conditions.
More Related Videos
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
03:17Inheritance of Chromatin Structures
02:36RNA Polymerase II Accessory Proteins
02:24Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
02:23Master Transcription Regulators
02:24Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
01:23Regulation of Expression at Multiple Steps